Gayer Charles K

Chief Commercial Officer at BCRX

Sold, on record
$66k
Dollars the filings state
Form 4 sales
1
Latest Dec 15, 2022
Form 144 notices
0
Proposed sales
Quarters with a sale
0 of the last 8
No sale in two years
Companies
1
Filed as an executive or holder

Companies

  • BCRXBIOCRYST PHARMACEUTICALS INCChief Commercial Officer

Sales by reason

0
Routine
1
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per year, every sale on record.

Sales chart range

Timeline

  1. Dec 15, 2022Plan not stated

    BCRX

    Sold 2.8% of their holdings

    $66k6,100 shares at $10.90

    Filed Dec 19, 2022Form 4

1 of 1

Every transaction

Every transaction on a Form 4 or Form 5 by Gayer Charles K
TradedFiledStockRoleWhatAmountPriceValueHeld afterSource
Dec 22, 2025Dec 23, 2025BCRXPresident and CCOExercised or settledEmp. Stock Option (Right to Buy)74,2330SEC
Dec 22, 2025Dec 23, 2025BCRXPresident and CCOExercised options74,233$5.01$372k952,583SEC
Dec 19, 2025Dec 23, 2025BCRXPresident and CCOWithheld for tax11,477$7.41$85k878,350SEC
Dec 17, 2025Dec 19, 2025BCRXPresident and CCOAwardedEmp. Stock Option (Right to Buy)986,950986,950SEC
Dec 17, 2025Dec 19, 2025BCRXPresident and CCOAwarded471,000889,827SEC
Dec 12, 2025Dec 16, 2025BCRXPresident and CCOWithheld for tax8,181$7.57$62k418,827SEC
Dec 19, 2024Dec 23, 2024BCRXChief Commercial OfficerWithheld for tax2,461$7.39$18k423,546SEC
Dec 19, 2024Dec 23, 2024BCRXChief Commercial OfficerAwardedEmp. Stock Option (Right to Buy)260,950260,950SEC
Dec 19, 2024Dec 23, 2024BCRXChief Commercial OfficerAwarded125,950426,007SEC
Dec 14, 2024Dec 17, 2024BCRXChief Commercial OfficerWithheld for tax8,251$7.53$62k300,057SEC
May 13, 2024May 15, 2024BCRXChief Commercial OfficerBought30,000$5.47$164k307,533SEC
Dec 19, 2023Dec 20, 2023BCRXChief Commercial OfficerWithheld for tax2,482$6.05$15k274,533SEC
Dec 14, 2023Dec 18, 2023BCRXChief Commercial OfficerWithheld for tax5,840$6.43$38k277,015SEC
Dec 14, 2023Dec 18, 2023BCRXChief Commercial OfficerAwardedEmp. Stock Option (Right to Buy)158,500158,500SEC
Dec 14, 2023Dec 18, 2023BCRXChief Commercial OfficerAwarded34,000282,855SEC
Dec 19, 2022Dec 21, 2022BCRXChief Commercial OfficerAwardedEmp. Stock Option (Right to Buy)158,500158,500SEC
Dec 19, 2022Dec 21, 2022BCRXChief Commercial OfficerAwarded34,000245,610SEC
Dec 15, 2022Dec 19, 2022BCRXChief Commercial OfficerSold6,100$10.90$66k211,610SEC
Dec 14, 2021Dec 16, 2021BCRXChief Commercial OfficerAwardedEmp. Stock Option (Right to Buy)164,000164,000SEC
Dec 14, 2021Dec 16, 2021BCRXChief Commercial OfficerAwarded125,000261,556SEC
Dec 15, 2020Dec 17, 2020BCRXVice President and CCOAwardedEmp. Stock Option (Right to Buy)190,000190,000SEC

Sales and notices (1)

Form 144 notices and Form 4 sales by Gayer Charles K
Source
Dec 15, 2022Dec 19, 2022BCRXChief Commercial OfficerForm 4 sale6,100$66k2.8%Plan not statedSEC